What is NUCLEAR?
NUCLEAR: ELUCIDATING METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY WITH RELEVANCE TO STEM CELL BIOLOGY AND CANCER
NUCLEAR is a Marie Skłodowska Curie Action Doctoral Network funded by the European Commission under the Horizon Europe framework programme.
NUCLEAR will train 17 Doctoral candidates (DC) in the emerging field of Metabolic Regulation of Genome Function and Cell Identity, relevant for stem cell biology and cancer. In total, there are 14 beneficiaries and 12 partner organisations.
NUCLEAR will bring together European leaders in the fields of metabolomics, functional genomics, chromatin regulation, stem cell biology, and cancer with innovators in precision nutrition, mass spectrometry technologies, and drug development.
NUCLEAR project aims to develop tools for the detection of metabolism in the nucleus, to understand how metabolism regulates functions of the chromatin template and to test metabolism-chromatin interactions as targetable vulnerabilities in cancer cells
NEWS
Recent Posts
- 16 PhD positions in Metabolic Genome Regulation 10 March 2025
- 16 Doctoral Candidate Positions Opening Soon 18 December 2024
- Breaking new ground in cancer and stem cell research: the NUCLEAR project launches 18 November 2024